Angiogenesis & Matrix
BPC-157
A gastric pentadecapeptide studied in angiogenesis and nitric-oxide signalling models.
- Molecular weight
- 1419.5 g/mol
- Presentation
- 5 or 10 mg vial
- Receptor targets
- VEGF, NO synthase, GH receptor crosstalk
RESEARCH USE ONLY · LYOPHILIZED PEPTIDES · NORTH CAROLINA
Kodiac biolabs sources, lyophilizes, and fulfills research peptides for serious investigators. Every batch is HPLC-verified by our supplier with documentation published in full. Independent Janoshik third-party verification is in progress. Every order ships cold-chain.
Kodiac exists because research compounds deserve laboratory rigor, not gray-market shortcuts. We source from disciplined manufacturers, publish the supplier’s HPLC report for every batch, and document every lot with a publicly retrievable certificate of analysis. The work the science requires is the work we do.
≥98% vendor HPLC purity · Janoshik verification pending · Cold-chain shipped
Latest monograph
Monograph library
A next-generation ACTH(4-10) analog engineered from Semax with N-terminal acetylation and C-terminal adamantylglycine amidation, designed to extend plasma half-life and central nervous system bioavailability while preserving the parent compound’s neurotrophic, neuroprotective, and monoaminergic pharmacology.
Angiogenesis & Matrix
A gastric pentadecapeptide studied in angiogenesis and nitric-oxide signalling models.
Angiogenesis & Matrix
A synthetic actin-binding fragment of thymosin beta-4 studied in cell-migration models.
Growth Hormone Axis
A selective GHRP studied for ghrelin receptor modulation.
Growth Hormone Axis
A GHRH analog studied without DAC modification.
Pineal Peptides
A tetrapeptide bioregulator studied for telomerase activity.
We started Kodiac because the research-compound market was full of products and empty of proof.
Most vendors photograph a vial, write a tagline, and call it credibility. We took the longer route. Bulk peptide sourced from a disciplined manufacturer, with the vendor certificate of analysis published for every lot and the HPLC, mass spectrometry and NMR reports wherever the vendor supplied them. Independent Janoshik third-party verification is in progress and will be published alongside the existing reports as it completes. Every lot is documented, scanned, and posted publicly so investigators can verify before they buy.
That is the entire model. Source carefully. Verify independently. Document everything. Ship cold. Disclose the rest.
LATEST MONOGRAPHS
MONOGRAPH
An acetylated thioester derivative of reduced glutathione engineered to resist gastrointestinal hydrolysis and deliver intact glutathione equivalents to the intracellular compartment via passive membrane permeation and subsequent cytoplasmic thioesterase-mediated deacetylation.
MONOGRAPH
A 34-amino-acid synthetic analog of human parathyroid hormone-related protein (1-34) engineered for selective activation of the RG conformation of the PTH type 1 receptor, producing transient osteoanabolic cAMP signaling with reduced bone resorption and hypercalcemia relative to teriparatide, approved for the treatment of osteoporosis in postmenopausal women and men at high fracture risk.
MONOGRAPH
A recombinant soluble decoy receptor comprising the extracellular domain of human activin receptor type IIB fused to the Fc domain of human immunoglobulin G1, developed by Acceleron Pharma as a systemic ligand trap for myostatin and related TGF-beta superfamily negative regulators of skeletal muscle mass.
One email a quarter: new lots with their certificates of analysis, and new monographs. Nothing else.